Significantly Strengthened Liquidity with Highly Successful $2.4 Billion Capital RaiseWell-Positioned to Withstand Over 18 Months of Voyage SuspensionsNon-Cash Goodwill and […]
Virtual oral presentation reviews interim clinical biomarker data for SGT-001 and provides data on expression and co-localization of microdystrophin and […]
NEW HAVEN, Conn., May 14, 2020 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical […]